Dr. Alysa Doyle is Director of Neuropsychology in the Clinical and Research Program in Pediatric Psychopharmacology and Assistant Professor of Psychiatry at Harvard Medical School. She joined the Psychiatric and Neurodevelopmental Genetics Unit in 2005.
Dr. Doyle’s research interests lie at the junction of developmental psychopathology, developmental neuropsychology and psychiatric genetics. Her focus is on using tools from genetics and neuropsychology to study risk mechanisms underlying the etiology and comorbidity of attention-deficit hyperactivity disorder (ADHD), pediatric bipolar disorder and early-onset antisocial behavior. Currently, she is the recipient of a Mentored Clinical Scientist Development Award from the National Institute of Mental Health entitled “The genetics of executive functions in ADHD and non-ADHD families.” The goals of this grant are to evaluate the utility of neuropsychological impairments as endophenotypes for ADHD and to identify the genetic underpinnings of deficits in executive functions. Dr. Doyle’s research is conducted in collaboration with Drs Joseph Biederman and Steve Faraone, under whose mentorship she has worked since 1998. She also collaborates with Drs. Pamela Sklar and Jordan Smoller on molecular genetic studies and is a co-investigator on Dr. David Pauls’ family/genetic study of ADHD, obsessive-compulsive disorder and Gilles de la Tourette syndrome.
Dr. Doyle earned her BA in English and Psychology from Williams College and received a PhD in child and adult clinical psychology from the University of Minnesota. She completed her doctoral thesis under Drs Bill Iacono and Matt McGue and received a Dissertation Research Award from the American Psychological Association. She completed her pre-doctoral internship and post-doctoral fellowship in the Department of Psychiatry at Massachusetts General Hospital, Harvard Medical School.
Reference Link:
|
